.png)
Agenzia Italiana del Farmaco
home
COVID-19
Learn more
Highlights
-
24 May 2022
COVID-19 emergency
Expansion of prescription criteria for antiviral medicines
AIFA makes available the new therapeutic plan for the prescription of Paxlovid.
-
20 May 2022
Monitoring Registers
Monitoring of antivirals for COVID-19: eleventh report published
The Italian Medicines Agency (AIFA) has published the results of the monitoring of antivirals currently available for treating COVID-19.
-
19 May 2022
Information and communication
Workshop "The role of In Silico Medicine in diabetes"
On 26 May 2022 AIFA, in collaboration with the Virtual Physiological Human Institute, will be hosting a workshop on “The role of In Silico Medicine in diabetes”.
-
25 May 2022
Fondi regionali di farmacovigilanza
Al via il Bando AIFA per l’informazione scientifica indipendente sui medicinali
Il 12 maggio 2022 il Consiglio di Amministrazione dell’Agenzia ha autorizzato l’utilizzo di circa 5 milioni di euro per finanziare attività di informazione scientifica indipendente sui medicinali.
News
20 May 2022
Monitoring Registers
Monitoring of monoclonal antibodies for COVID-19: weekly report published
20 May 2022
Safety of medicinal products
Synchron Research Service: suspension of medicines over flawed studies
17 May 2022
Monitoring Registers
Hepatitis C: update of 16 May 2021 concerning enrolled patients
16 May 2022
Transparency Lists
AIFA updates the Transparency Lists
13 May 2022
Authorisation of medicinal products
Updated submission modalities of Active Substance Master Files and subsequent amendments/updates
13 May 2022
Consumption and pharmaceutical expenditure
Monitoring of Pharmaceutical expenditure
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
